Identification of tumor-agnostic biomarkers for predicting prostate cancer progression and biochemical recurrence.

Front Oncol · 2023 · PMC10641020 · PMID 37965470

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

approached significanceno p-value reported

Both PGR (HR, 2.2; 95% IC, 0.88-5.84; P =0.08) and ESR1 (HR, 2.3; 95% IC, 0.92-5.9; P =0.07) exhibited a positive correlation with reduced BCRFS that approached significance ( Table 4 ).

also in 8,237 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.